Evidence map›Paper›PMID 33216117›Full record

ArticleThe Journal of experimental medicine2021

A mouse model of human TLR4 D299G/T399I SNPs reveals mechanisms of altered LPS and pathogen responses.

Katharina Richard, Kurt H Piepenbrink, Kari Ann Shirey, Archana Gopalakrishnan, Shreeram Nallar, Daniel J Prantner, Darren J Perkins, Wendy Lai, Alexandra Vlk, Vladimir Y Toshchakov and 5 more

Open access · greenAbstract read
In one paragraph

Article in The Journal of experimental medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
1.5field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 29 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Frontiers in cellular and infection microbiology · 2023
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. TLR4 Gene Polymorphisms Interaction WithFrontiers in pediatrics · 2022
    Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 4 institutions in 1 country.

Katharina RichardDepartment of Microbiology and Immunology, University of Maryland, School of Medicine, Baltimore, MD.
Kurt H PiepenbrinkDepartment of Food Science and Technology, Department of Biochemistry, University of Nebraska, Lincoln, NE.
Kari Ann ShireyDepartment of Microbiology and Immunology, University of Maryland, School of Medicine, Baltimore, MD.
Archana GopalakrishnanDepartment of Microbiology and Immunology, University of Maryland, School of Medicine, Baltimore, MD.
Shreeram NallarDepartment of Microbiology and Immunology, University of Maryland, School of Medicine, Baltimore, MD.
Daniel J PrantnerDepartment of Microbiology and Immunology, University of Maryland, School of Medicine, Baltimore, MD.
Darren J PerkinsDepartment of Microbiology and Immunology, University of Maryland, School of Medicine, Baltimore, MD.
Wendy LaiDepartment of Microbiology and Immunology, University of Maryland, School of Medicine, Baltimore, MD.
Alexandra VlkDepartment of Microbiology and Immunology, University of Maryland, School of Medicine, Baltimore, MD.
Vladimir Y ToshchakovDepartment of Microbiology and Immunology, University of Maryland, School of Medicine, Baltimore, MD.
Chiguang FengCenter for Vaccine Development, University of Maryland, School of Medicine, Baltimore, MD.
Rachel FanaroffDepartment of Anatomical Pathology, University of Maryland Medical Center, Baltimore, MD.
Andrei E MedvedevDepartment of Immunology, University of Connecticut Health Center, Farmington, CT.
Jorge C G BlancoSigmovir Biosystems, Inc., Rockville, MD.
Stefanie N VogelDepartment of Microbiology and Immunology, University of Maryland, School of Medicine, Baltimore, MD.
University of Maryland, Baltimore · USSigmovir Biosystems (United States) · USUConn Health · USUniversity of Nebraska–Lincoln · US

Funding

Deciphering the architecture of TLR signaling complexesR01AI082299 · NIAID · UNIVERSITY OF MARYLAND BALTIMORE · PI TOSHCHAKOV, VLADIMIR Y. · 2010 to 2020
$3.8M
Eritoran (E5564), a TLR4 antagonist, as a novel therapeutic for influenzaR01AI104541 · NIAID · UNIVERSITY OF MARYLAND BALTIMORE · PI BLANCO, JORGE C, VOGEL, STEFANIE N. · 2013 to 2016
$3.4M
Targeting TLR Signaling Pathways to Blunt Pathogen-mediated Acute Lung InjuryR01AI125215 · NIAID · UNIVERSITY OF MARYLAND BALTIMORE · PI BLANCO, JORGE C, VOGEL, STEFANIE N. · 2017 to 2021
$2.7M
Macrophage differentiation and disease outcome in influenza infectionR01AI123371 · NIAID · UNIVERSITY OF MARYLAND BALTIMORE · PI VOGEL, STEFANIE N. · 2017 to 2021
$2.7M
RSV-induced M2 macrophage differentiation: role of TLR4/PPARg/RXR signaling axis (80)R21AI163543 · NIAID · UNIVERSITY OF MARYLAND BALTIMORE · PI BLANCO, JORGE C, VOGEL, STEFANIE N. · 2021 to 2022
$432k
Structural Basis of Type IV Pilus-Induced Clostridium difficile Microcolony FormationK22AI123467 · NIAID · UNIVERSITY OF NEBRASKA LINCOLN · PI PIEPENBRINK, KURT HENRY · 2017 to 2018
$260k
Analysis of Cellular Metabolism using Seahhorse TechnologyS10OD025101 · OD · UNIVERSITY OF MARYLAND BALTIMORE · PI VOGEL, STEFANIE N. · 2019 to 2019
$205k
Biocatalytic Methods for the Asymmetric Synthesis of AminesF32GM133126 · NIGMS · CALIFORNIA INSTITUTE OF TECHNOLOGY · PI YANG, YANG · 2019 to 2020
$77k
NIAID NIH HHS K22 AI123467NIAID NIH HHS R01 AI082299NIAID NIH HHS R01 AI104541NIAID NIH HHS R01 AI123371NIAID NIH HHS R01 AI125215NIGMS NIH HHS F32 GM133126NIH HHS S10 OD025101
6 · The paper itself

Abstract

Two cosegregating single-nucleotide polymorphisms (SNPs) in human TLR4, an A896G transition at SNP rs4986790 (D299G) and a C1196T transition at SNP rs4986791 (T399I), have been associated with LPS hyporesponsiveness and differential susceptibility to many infectious or inflammatory diseases. However, many studies failed to confirm these associations, and transfection experiments resulted in conflicting conclusions about the impact of these SNPs on TLR4 signaling. Using advanced protein modeling from crystallographic data of human and murine TLR4, we identified homologous substitutions of these SNPs in murine Tlr4, engineered a knock-in strain expressing the D298G and N397I TLR4 SNPs homozygously, and characterized in vivo and in vitro responses to TLR4 ligands and infections in which TLR4 is implicated. Our data provide new insights into cellular and molecular mechanisms by which these SNPs decrease the TLR4 signaling efficiency and offer an experimental approach to confirm or refute human data possibly confounded by variables unrelated to the direct effects of the SNPs on TLR4 functionality.

Indexed as

AnimalsDisease Models, AnimalFemaleGenetic Predisposition to DiseaseHumansLipopolysaccharidesMaleMicePolymorphism, Single NucleotideSignal TransductionToll-Like Receptor 4LipopolysaccharidesTLR4 protein, humanToll-Like Receptor 4

Identifiers

PMID33216117
PMCPMC7685774
OpenAlexW3102725912

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.